Skip to main content
OpenTrials
Completed

NCT Number: NCT04280887

MyPad - Intelligent Bladder Pre-void Alerting System

Development a 'dry alarm' that can help children and adolescents become dry at night.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lancashire Teaching Hospitals NHS Foundation Trust

Preston, United Kingdom

About this study

Enuresis / Bedwetting is a common problem causing much emotional distress. Most children are dry by the age of 5 years, but a significant number of older children still wet their bed. This can be very distressing for child and family. There is also an associated cost due to extra laundry and impact of lost sleep.

Programmes to help children become dry at night often include the use of a moisture alarm. The alarms sound when the child begins to wet the bed, waking them up to go to the toilet instead. Most alarms work by detecting wetness, sounding the alarm when the child starts to pass urine. As such, they still need to change pyjamas and bed sheets.

The investigators aim to develop a 'dry alarm' that can help children and adolescents become dry at night. The alarm will sound when the bladder is full, before the child passes urine. This would avoid wet beds. The investigators have engineered parts for this alarm, but need to work on making it ready for use. This device will enable children to have dry nights whilst learning bladder control.

This study has several phases. The alarm will consist of a small box worn over the abdomen. The aim is to test this overnight, and adjust it for comfort and ease. The device uses a mini ultrasound machine, which measures how much urine is in the bladder. There will be a series of tests to calibrate the device compared to a clinical ultrasound device. Then children with enuresis/ bed wetting will wear it overnight. It will be linked to an alarm which will sound once the bladder is full.

This particular study will determine the feasibility of the product, to confirm the design and specifications, including a comfort trial, calibration and comparison with clinical scans, and operating process prior to a future clinical trial.

The total number of participants is 25 - however this will be split over the different phases of the trial.

Comfort Trial - 5 Calibration trial 3 month testing phase - 10

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 7 years to 12 years
  • Bedwetting twice a week or more
  • Good understanding of English language
  • For the initial comfort trials and the calibration trial healthy volunteers may be invited to take part.

Exclusion criteria

  • there is a medical cause for bedwetting
  • they have significant learning difficulties
  • they are obese (above 98th centile for Body Mass Index)
  • they have severe hearing impairment

Treatment and study plan

MyPad

Device

Ultrasound bed wetting alarm

Primary outcomes

  1. Bladder expansion

    Time frame: 3 months

    Bladder size measurements, device is able to provide consistent readings

  2. Reduction in adverse events

    Time frame: 3 months

    Number of adverse events measured over the three months - reduction over time

Secondary outcomes

  1. Comfort

    Time frame: 3 months

    Comfort, design and tolerability of device using validated comfort tool

Sponsors and collaborators

Lead sponsor

Lancashire Teaching Hospitals NHS Foundation Trust

Other

Collaborators

  • University of Central Lancashire

Registry information

Acronym: MyPad

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
Feb 21, 2020
Registry last updated
Nov 10, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.